US Stock MarketDetailed Quotes

PHAR Pharming Group

Watchlist
  • 9.890
  • -0.570-5.45%
Close Jan 3 16:00 ET
670.89MMarket Cap-36.63P/E (TTM)

Pharming Group Key Stats

Pharming Group Q3 2024 Earnings Date

Currency:USDOct 24, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
77.56M
74.85M
-2.71M
Miss Est.
+16.43%
+12.28%
-3.50%
EPS
-<0.01
-0.02
-0.02
Miss Est.
-148.00%
-140.00%
-733.33%
Strong Buy

Dec 31, 2024

Pharming Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 60.928M--
--2024/Q4-- / 76.667M--
Oct 24, 20242024/Q369.422M / 69.657M--
Aug 1, 20242024/Q268.462M / 66.479M--
May 8, 20242024/Q151.723M / 65.541M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 60.928M--
--2024/Q4-- / 76.667M--
Oct 24, 20242024/Q369.422M / 69.657M--
Aug 1, 20242024/Q268.462M / 66.479M--
May 8, 20242024/Q151.723M / 65.541M--

Unlock Free Earnings Estimates

Pharming Group Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 31, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data